Index -
P/E 107.07
EPS (ttm) 1.73
Insider Own 1.74%
Shs Outstand 29.74M
Perf Week 1.90%
Market Cap 5.51B
Forward P/E 58.08
EPS next Y 3.20
Insider Trans -6.55%
Shs Float 29.15M
Perf Month 5.26%
Income 53.51M
PEG 3.07
EPS next Q -0.24
Inst Own 110.03%
Short Float 8.65%
Perf Quarter -2.69%
Sales 802.80M
P/S 6.86
EPS this Y 23.83%
Inst Trans -3.05%
Short Ratio 4.72
Perf Half Y -2.43%
Book/sh 23.19
P/B 8.00
EPS next Y 47.46%
ROA 7.21%
Short Interest 2.52M
Perf Year -1.36%
Cash/sh 15.02
P/C 12.36
EPS next 5Y 34.91%
ROE 8.48%
52W Range 123.00 - 257.40
Perf YTD 0.12%
Dividend Est. -
P/FCF 60.44
EPS past 5Y -
ROI 7.43%
52W High -27.89%
Beta 1.47
Dividend TTM -
Quick Ratio 6.22
Sales past 5Y 59.87%
Gross Margin 84.68%
52W Low 50.90%
ATR (14) 8.97
Dividend Ex-Date -
Current Ratio 7.13
EPS Y/Y TTM 345.48%
Oper. Margin 4.49%
RSI (14) 47.82
Volatility 5.30% 4.53%
Employees 1246
Debt/Eq 0.05
Sales Y/Y TTM 28.49%
Profit Margin 6.67%
Recom 1.60
Target Price 235.88
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q 134.62%
Payout 0.00%
Rel Volume 1.27
Prev Close 187.15
Sales Surprise 1.25%
EPS Surprise 57.21%
Sales Q/Q 24.52%
Earnings Feb 10 AMC
Avg Volume 534.25K
Price 185.61
SMA20 -1.08%
SMA50 -1.86%
SMA200 2.16%
Trades
Volume 679,146
Change -0.82%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-20-24 Upgrade
BofA Securities
Neutral → Buy
$220 → $255
May-08-24 Downgrade
BofA Securities
Buy → Neutral
$265 → $225
Apr-19-24 Initiated
RBC Capital Mkts
Outperform
$285
Mar-19-24 Initiated
Morgan Stanley
Overweight
$250
Feb-06-24 Resumed
KeyBanc Capital Markets
Overweight
$278
Jan-19-24 Initiated
Jefferies
Buy
$245
Jan-02-24 Downgrade
Stifel
Buy → Hold
$210
Dec-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$245 → $187
Jul-19-23 Initiated
Robert W. Baird
Outperform
$371
Apr-14-23 Initiated
Mizuho
Buy
$300
Mar-29-23 Initiated
UBS
Buy
$300
Dec-13-22 Upgrade
Goldman
Neutral → Buy
$245 → $308
Dec-13-22 Initiated
KeyBanc Capital Markets
Overweight
$287
Apr-13-22 Initiated
Truist
Buy
$315
Apr-06-22 Initiated
Wolfe Research
Peer Perform
$270
Mar-02-22 Resumed
BofA Securities
Buy
$270
Jan-04-21 Downgrade
BofA Securities
Buy → Neutral
Dec-15-20 Downgrade
Goldman
Buy → Neutral
$162 → $209
Nov-03-20 Upgrade
Oppenheimer
Underperform → Perform
Nov-03-20 Upgrade
BofA Securities
Neutral → Buy
$125 → $155
Show Previous Ratings
Feb-12-25 09:45AM
Feb-11-25 08:40AM
(Thomson Reuters StreetEvents)
07:01AM
02:08AM
Feb-10-25 05:30PM
05:10PM
Loading…
05:10PM
04:19PM
04:02PM
Feb-09-25 08:02AM
Feb-07-25 07:07AM
Feb-05-25 09:15AM
Feb-03-25 10:00AM
Jan-13-25 06:45AM
Jan-09-25 07:30AM
(Investor's Business Daily)
Jan-07-25 09:50AM
08:00AM
Loading…
08:00AM
Jan-06-25 08:15AM
Dec-30-24 08:00AM
Dec-23-24 02:25PM
Dec-05-24 12:12PM
Dec-04-24 11:30AM
Nov-20-24 02:08PM
Nov-19-24 08:00AM
Nov-18-24 10:00AM
Nov-15-24 08:00AM
Nov-11-24 06:45AM
Nov-06-24 08:00AM
06:31AM
Nov-05-24 02:09AM
Nov-04-24 06:30PM
05:20PM
Loading…
05:20PM
04:02PM
Oct-30-24 09:15AM
08:00AM
Oct-18-24 12:00PM
Oct-11-24 12:15PM
Oct-07-24 08:00AM
Oct-04-24 05:04PM
Sep-18-24 09:50AM
Sep-06-24 06:43PM
Sep-02-24 09:50AM
Aug-23-24 07:35AM
Aug-21-24 04:02PM
Aug-09-24 12:20PM
Aug-07-24 10:48AM
Aug-06-24 06:30PM
05:35PM
04:02PM
04:02PM
Aug-05-24 10:10AM
09:16AM
Aug-02-24 08:00AM
Jul-29-24 10:59AM
09:21AM
06:45AM
Jul-23-24 08:00AM
Jul-22-24 11:35AM
08:39AM
08:00AM
04:52AM
Jul-19-24 08:00AM
08:00AM
Jul-13-24 08:36AM
Jul-10-24 11:08AM
Jul-09-24 03:17PM
Jul-02-24 08:00AM
Jun-25-24 08:30AM
Jun-24-24 04:10PM
(Investor's Business Daily) -16.72%
02:01PM
10:08AM
(The Wall Street Journal)
Jun-06-24 11:31AM
Jun-04-24 08:00AM
May-28-24 06:00AM
May-23-24 08:00AM
May-21-24 12:40PM
May-09-24 09:35AM
May-08-24 01:49PM
11:33AM
10:16AM
(Thomson Reuters StreetEvents)
09:30AM
07:31AM
May-07-24 08:59PM
05:46PM
05:10PM
04:02PM
May-03-24 09:15AM
Apr-30-24 06:15PM
03:39PM
(Investor's Business Daily)
08:00AM
Apr-26-24 09:14AM
Apr-18-24 12:17PM
02:14AM
Apr-17-24 08:38AM
(The Wall Street Journal) +9.87%
Apr-08-24 05:17AM
Apr-02-24 08:00AM
Mar-27-24 07:00PM
Mar-21-24 02:31AM
Mar-18-24 12:01PM
Mar-14-24 01:49AM
Mar-05-24 08:00AM
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rondoni John Chief Technology Officer Feb 11 '25 Sale 170.49 583 99,396 10,424 Feb 13 08:14 PM RANDALL BAN Officer Feb 13 '25 Proposed Sale 187.01 25,584 4,784,464 Feb 13 04:30 PM JOHN RONDONI Officer Feb 11 '25 Proposed Sale 170.49 583 99,396 Feb 11 04:01 PM Rondoni John Chief Technology Officer Jan 07 '25 Sale 215.00 58 12,470 11,322 Jan 10 04:05 PM JOHN RONDONI Officer Jan 07 '25 Proposed Sale 215.00 58 12,470 Jan 07 04:02 PM Rondoni John Chief Technology Officer Nov 01 '24 Option Exercise 61.38 8,703 534,219 20,051 Nov 05 04:01 PM Rondoni John Chief Technology Officer Nov 01 '24 Sale 193.47 8,703 1,683,731 11,348 Nov 05 04:01 PM JOHN RONDONI Officer Nov 01 '24 Proposed Sale 193.46 8,703 1,683,723 Nov 01 04:47 PM Ebeling Philip Officer Sep 11 '24 Proposed Sale 247.28 5,453 1,348,445 Sep 11 06:01 PM McCormick Shawn Director Sep 09 '24 Sale 220.00 800 176,000 23,140 Sep 11 05:02 PM Rondoni John Chief Technology Officer Sep 09 '24 Sale 215.00 31 6,665 11,348 Sep 11 05:01 PM SHAWN T MCCORMICK Director Sep 09 '24 Proposed Sale 220.00 800 176,000 Sep 09 04:09 PM JOHN RONDONI Officer Sep 09 '24 Proposed Sale 215.00 31 6,665 Sep 09 04:08 PM Rondoni John Chief Technology Officer Aug 22 '24 Option Exercise 71.00 5,000 355,000 16,379 Aug 23 04:09 PM Rondoni John Chief Technology Officer Aug 22 '24 Sale 189.83 5,000 949,143 11,379 Aug 23 04:09 PM JOHN RONDONI Officer Aug 22 '24 Proposed Sale 189.82 5,000 949,100 Aug 22 04:22 PM Ban Randy Chief Commercial Officer Aug 15 '24 Option Exercise 42.15 16,139 680,259 19,195 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 16 '24 Option Exercise 42.15 4,861 204,891 7,917 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 15 '24 Sale 193.10 16,139 3,116,397 3,056 Aug 19 08:14 PM Ban Randy Chief Commercial Officer Aug 16 '24 Sale 188.55 4,861 916,549 3,056 Aug 19 08:14 PM RANDALL A BAN Officer Aug 16 '24 Proposed Sale 188.55 4,861 916,560 Aug 16 04:34 PM Ebeling Philip Officer Aug 15 '24 Proposed Sale 194.84 43,901 8,553,615 Aug 15 05:36 PM McCormick Shawn Director Aug 14 '24 Option Exercise 0.94 8,537 8,025 23,940 Aug 15 04:19 PM RANDALL A BAN Officer Aug 15 '24 Proposed Sale 193.10 16,139 3,116,380 Aug 15 04:13 PM Ebeling Philip Officer Aug 14 '24 Proposed Sale 190.03 4,596 873,393 Aug 14 04:50 PM Griffin Jerry C Director Jul 26 '24 Proposed Sale 126.53 5,952 753,086 Jul 26 05:02 PM McCormick Shawn Director May 10 '24 Option Exercise 0.94 2,500 2,350 15,403 May 13 04:30 PM NELSON MARILYN C Director Apr 29 '24 Option Exercise 240.68 1,175 282,799 35,620 May 01 04:01 PM Buchholz Richard Chief Financial Officer Apr 17 '24 Sale 230.03 15,000 3,450,450 28,271 Apr 18 04:44 PM Herbert Timothy P. CEO and President Apr 01 '24 Sale 205.09 40,000 8,203,581 63,658 Apr 03 07:44 PM Griffin Jerry C Director Apr 01 '24 Option Exercise 16.00 296 4,736 10,932 Apr 03 04:55 PM Griffin Jerry C Director Apr 01 '24 Sale 213.99 32 6,848 10,900 Apr 03 04:55 PM NELSON MARILYN C Director Apr 01 '24 Option Exercise 16.00 3,273 52,368 34,338 Apr 02 08:29 PM NELSON MARILYN C Director Mar 27 '24 Option Exercise 90.85 3,243 294,633 31,065 Mar 29 04:49 PM Griffin Jerry C Director Mar 25 '24 Option Exercise 16.00 1,000 16,000 11,190 Mar 27 04:01 PM Griffin Jerry C Director Mar 25 '24 Sale 197.81 554 109,587 10,636 Mar 27 04:01 PM Rondoni John Chief Technology Officer Mar 22 '24 Sale 194.40 4,387 852,849 11,270 Mar 26 08:23 PM Griffin Jerry C Director Mar 18 '24 Option Exercise 16.00 1,000 16,000 10,744 Mar 20 05:51 PM Griffin Jerry C Director Mar 18 '24 Sale 193.53 554 107,216 10,190 Mar 20 05:51 PM Griffin Jerry C Director Mar 11 '24 Option Exercise 16.00 1,000 16,000 10,298 Mar 13 09:21 PM Griffin Jerry C Director Mar 11 '24 Sale 198.05 554 109,720 9,744 Mar 13 09:21 PM Griffin Jerry C Director Mar 01 '24 Option Exercise 16.00 1,000 16,000 9,852 Mar 05 05:08 PM Griffin Jerry C Director Mar 01 '24 Sale 179.44 554 99,410 8,298 Mar 05 05:08 PM NELSON MARILYN C Director Mar 01 '24 Option Exercise 0.94 2,555 2,402 27,822 Mar 05 05:06 PM Rondoni John Chief Technology Officer Feb 29 '24 Sale 179.25 8,605 1,542,441 15,657 Mar 04 06:21 PM Ban Randy Chief Commercial Officer Feb 27 '24 Option Exercise 42.15 3,060 128,979 6,089 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 23 '24 Option Exercise 4.11 12,230 50,234 15,259 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 23 '24 Sale 185.37 12,230 2,267,075 3,029 Feb 27 08:39 PM Ban Randy Chief Commercial Officer Feb 27 '24 Sale 182.01 3,060 556,951 3,029 Feb 27 08:39 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite